분자유전학실험실 (단국대학교 분자생물학과)


21   Selective expression of transgene using hypoxia-inducibletrans-splicing group I intron ribozyme  이성욱 2014/11/08 475
20   Selective regression of cancer cells expressing a splicing variant of AIMP2 through targeted RNA replacement by trans-splicing ribozyme  관리자 2012/02/17 994
19   Selective regression of cancer cells expressing a splicing variant of AIMP2 through targeted RNA replacement by trans-splicing ribozyme  이성욱 2012/12/04 850
18   Selective regression of cells expressing mouse cytoskeleton-associated protein 2 transcript by trans-splicing ribozyme. 2007 Oligonucleotides  이성욱 2007/05/02 1440
17   Sequence and Structural Features of RNA Aptamer Against Myasthenic Autoantibodies. (2009) 19: 273-279  관리자 2009/09/18 1332
16   Song, M.-S., and Lee, S.-W. (2006) Cancer-selective induction of cytotoxicity by tissue-specific expression of targeted trans-splicing ribozyme. FEBS Letters  이성욱 2006/09/13 1336
15   Specific and efficient regression of cancers harboring KRAS mutation by targeted RNA replacement. Molecular Therapy 2017; 25(2): 356-367.  이성욱 2017/02/02 355
14   Specific Regression of Human Cancer Cells by Ribozyme-Mediated Targeted Replacement of Tumor-Specific Transcript. Molecular Therapy  이성욱 2005/11/07 1615
13   Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells. Nature Medicine  관리자 2003/08/01 1747
12   Targeted anticancer effect through microRNA-181a regulated tumor-specific hTERT replacement. Cancr Letters 356 (2015) 918-928.  이성욱 2014/12/04 806
11   Targeted Regression of Hepatocellular Carcinoma by Cancer-Specific RNA Replacement through MicroRNA Regulation. Scientific Reports (2015) 5, 12315; doi: 10.1038/srep12315.  이성욱 2015/07/20 421
10   Targeting the MicroRNA Passenger Strand for Regulating Therapeutic Transgenes. Nucleic Acid Therapeutics (2015) 25(4): 209-218  이성욱 2015/07/22 342
9   The Role of MicroRNAs in Hepatitis C Virus Replication and Related Liver Diseases  이성욱 2014/06/05 625
8   Therapeutic applications of aptamer-based riboswitches. Nucleic Acid Therapeutics 2016: 26(1); 44-51  이성욱 2016/02/19 262
7   Therapeutic applications of group I intron-based trans-splicing ribozymes. WIREs RNA. 2018; 9: e1466.  이성욱 2018/04/24 124
6   TS ribozyme review-WIREs RNA-Cover Image 2018 Vol.9 No.3  이성욱 2018/04/24 138
5   Tumor-specific gene delivery using RNA-targeting Tetrahymena group I intron. Biotechnology Letters  이성욱 2005/06/23 1558
4   Use of tumor-targeting trans-splicing ribozyme for cancer treatment. Methods in Molecular Biology (2014) 1103: 83-95.  이성욱 2014/01/11 881
3   Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo. Cancer Gene Therapy (2009) 16: 113–125.  이성욱 2009/02/26 1619
2   Won, Y.-S., and Lee, S.-W. (2007) Targeted retardation of hepatocarcinoma cells by specific replacement of alpha-fetoprotein RNA. J. Biotechol. 129: 614-619  이성욱 2007/04/21 1538

[1][2][3] 4 [5]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN